Azithromycin Lactobionate

乳糖酸阿奇霉素

Report date: 2026/03/04 20:01:44

Base Information

Drug NameAzithromycin Lactobionate
Drug Alias Name齐宏
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics
Mechanisms of Action50S ribosomal subunit inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsPneumoniaPelvic Inflammatory Disease
Global Approved IndicationsPneumoniaPelvic Inflammatory Disease
Approved Indications in ChinaPneumoniaPelvic Inflammatory Disease
Original Approved Country/TerritoryMainland China
Original Approved Date2001/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsPneumoniaPelvic Inflammatory Disease
Inactive IndicationsN/A

Other Information

ATC CodeJ01FA10S01AA26
Related LinksN/A